Day One

Day Two

8:00 am Registration & Coffee

8:55 am Chair’s Opening Remarks

9:00 am Industry Leaders Fireside Chat: Pipeline Progress: Get Your Questions on the Pipelines of the Leading Allogeneic Developers Answered

  • Blake Aftab VP, Preclinical & Translational Science, Atara Biotherapeutics
  • Chris Bond VP, Cellular Engineering, Kite Pharma
  • Lan Cao Senior Director, Head of Product Development & Global Program Leader, Cell Therapy , Takeda
  • Mark Leonard VP, Process & Product Development , Allogene Therapeutics
  • Arthur Stril Vice President, Corporate Development, Cellectis
  • Kuldeep Singh Neote VP, External Innovations , Eli Lilly

10:00 am Commercially Viable iPSC-Based Therapies – a CDMO View

  • Marcos Langtry Head of Allogeneic Cell Therapy Commercial Development , Lonza Pharma & Biotech

10:30 am Speed Networking

11:00 am Morning Refreshments

11:30 am Century Therapeutics iPSC-derived Allogeneic Cell Therapies for Cance

12:00 pm Streamlining Cell & Gene Therapy Development with an Integrated Platform of High Quality Cellular Materials, In-House Apheresis Capabilities & Multi-Omics Analytical Services

12:30 pm Lunch & Networking

3:00 pm Afternoon Refreshments & Poster Session

5:00 pm End of Day 1

Evening Drinks Reception

Synopsis

After a busy day of learning and networking, unwind with your new colleagues over a drink and forge long lasting relationships

Day 2